Digitally supported personalized nutrition to improve heart pumping after ST‑elevation heart attack
Official title: Effect of Digitally Supported Medical Nutrition Therapy on Left Ventricular Ejection Fraction in Patients With ST-Elevation Myocardial Infarction: A Randomized Controlled Trial
Run by Saglik Bilimleri Universitesi · NCT07427199 · Data updated 2026-11-12
This program will test whether a three-month personalized diet plan with digital support can improve heart pumping (left ventricular ejection fraction) in adults who recently had a STEMI.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 19 Years to 65 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Saglik Bilimleri Universitesi Academic / other |
| Locations | 1 site (Samsun, Atakum) |
| Status | Recruiting |
| Started | December 30, 2025 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | February 23, 2026 |
| Trial ID | NCT07427199 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 19–65 who had a recent ST‑elevation myocardial infarction, meet the specified BMI ranges, can enroll within 72 hours of hospital admission, and can commit to three months of follow-up are ideal candidates.
✕Probably not a fit
Patients over 65, those with recent significant weight loss, active cancer, chronic renal failure, severe systemic disease, major cognitive impairment, or prior nutrition education are excluded and unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults who had a STEMI and meet the age and BMI criteria are enrolled within 72 hours of hospital admission and receive tailored medical nutrition therapy supported by digital content for three months. Dietary guidance is delivered via digital materials and participants follow the program while attending follow-up visits. Heart function (left ventricular ejection fraction) is measured at baseline, one month, and three months, and adherence and clinical data are recorded. The interventional single-center protocol is conducted at Ondokuz Mayıs Üniversitesi Tıp Fakültesi Hastanesi in Samsun, Turkey.
Why it matters
Potential benefit: If successful, the program could improve left ventricular ejection fraction after STEMI and make practical dietary support more accessible during recovery.
How similar studies have gone: While cardiac rehab and dietary programs have shown benefits after MI, digitally supported medical nutrition specifically aimed at improving LVEF after STEMI is relatively new and has limited prior evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals aged 19-65 who have fully completed the voluntary consent form * Being of normal weight (BMI 18.5-24.9 kg/m²) or obese (30-34.99 kg/m²) * Having suffered a heart attack with ST elevation (STEMI) * To be enrolled in the study within the first 72 hours after hospital admission * To be willing to participate in a follow-up period of at least 3 months Exclusion Criteria: * Those who did not sign the voluntary consent form * Individuals aged over 65 * Weight loss exceeding 5% in the last 3 months * Those with malignancy, chronic renal failure or severe systemic disease * Patients unable to complete the questionnaires due to severe cognitive impairment * Those who have previously received nutrition education or eating awareness training
Where it's running
-
Ondokuz Mayıs Üniversitesi Tıp Fakültesi Hastanesi
Samsun, Atakum, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Sena Yücel
- Email: senayucel633@gmail.com
- Phone: +90 530 118 8468
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Reducing slow-flow and no-reflow during STEMI with a high-dose intracoronary adenosine protocol
In STEMI patients undergoing primary PCI, this trial tests whether giving a high-dose intracoronary adenosine before balloon or stent inflation can prevent slow-flow or no-reflow.
-
Drug-coated balloons vs drug-eluting stents for immediate slow-flow/no-reflow in STEMI with high thrombus
This study tests whether using a drug-coated balloon instead of a drug-eluting stent during PCI helps reduce immediate slow-flow or no-reflow in STEMI patients with high thrombus burden.
-
CHIP in STEMI: Does clonal hematopoiesis influence infarct severity
This study tests whether clonal hematopoiesis (CHIP) affects infarct size and microvascular injury in people having a heart attack treated with PCI.
-
Giving heparin before arrival for people with STEMI who will have primary PCI.
This trial will test whether giving an IV loading dose of unfractionated heparin before hospital arrival helps adults with STEMI who are going for primary PCI.
-
Investigating microplastics in patients with heart attacks
This study is testing whether tiny plastic particles found in the body affect heart health in patients who have had a heart attack and are getting urgent treatment.
-
PDGFRβ PET imaging to detect cardiac fibrosis after heart attack or in HFpEF
This project will test whether a PET tracer that binds PDGFRβ can spot fibrogenic cells in the hearts of people after a STEMI, in patients with HFpEF, and in healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.